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Platelet-derived growth factors (PDGFs) and their ty-
rosine kinase receptors (PDGFRs) are known to play
important roles during development of the lungs,
central nervous system (CNS), and skeleton and in
several diseases. PDGF-C is a ligand for the tyrosine
kinase receptor PDGFR. Mutations in the gene en-
coding PDGF-C have been linked to clefts of the lip
and/or palate in humans, and ablation of PDGF-C in
129/Sv background mice results in death during the
perinatal period. In this study, we report that ablation
of PDGF-C in C57BL/6 mice results in a milder phe-
notype than in 129/Sv mice, and we present a pheno-
typic characterization of PDGF-C deficiency in the
adult murine CNS. Multiple congenital defects were
observed in the CNS of PDGF-C–null C57BL/6 mice,
including cerebral vascular abnormalities with abnor-
mal vascular smooth muscle cell coverage. In vivo
imaging of mice deficient in PDGF-C also revealed
cerebral ventricular abnormalities, such as asymme-
try of the lateral ventricles and hypoplasia of the
septum, reminiscent of cavum septum pellucidum in
humans. We further noted that PDGF-C–deficient
mice displayed a distorted ependymal lining of the
lateral ventricles, and we found evidence of mis-
placed neurons in the ventricular lining. We con-
clude that PDGF-C plays a critical role in the develop-
ment of normal cerebral ventricles and neuroepen-
1136dymal integrity as well as in normal cerebral vascu-
larization. (Am J Pathol 2012, 180:1136–1144; DOI:
10.1016/j.ajpath.2011.12.006)
Platelet-derived growth factors (PDGFs) and their tyrosine
kinase receptors (PDGFRs) are well known to play crucial
roles during development and in several diseases.1 Cur-
rently, there are four known PDGFs, PDGF-A through
PDGF-D, that signal via two PDGFRs, PDGFR and
PDGFR. PDGFR signaling has been shown to primarily
direct the development of vascular mural cells, whereas
PDGFR signaling has been implicated in numerous devel-
opmental processes, including gonad, lung, central ner-
vous system (CNS), and skeletal development.
PDGF-C is secreted as a latent disulphide-linked ho-
modimer (PDGF-CC) that requires proteolytic activation
to induce signaling via PDGFR.2 We previously showed
that tissue plasminogen activator can activate PDGF-CC3
and that activation in the neurovascular unit leads to
increased vascular permeability.4 PDGF-C/PDGFR sig-
naling was found to be involved in the loss of blood-brain
barrier function during stroke, and pharmacologic inhibi-
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tinib or with neutralizing antibodies to PDGF-C improved
blood-brain barrier integrity.4 However, further dissection
of this novel role for PDGF signaling using PDGF-C– or
PDGFR–deficient mice was not feasible since PDGFR
and PDGF-C ablation in mice was reported to result in
embryonic or perinatal lethality.5,6 However, the severity
of PDGF-C ablation seems to depend on the genetic
background of the mice.7
In this study, we demonstrate that PDGF-C deficiency
on a C57BL/6 background is largely compatible with
postnatal life, thus offering the opportunity to study the
physiologic and pathophysiologic roles of this protein in
the adult mouse. However, these PDGF-C–deficient mu-
tants present numerous congenital defects, including ce-
rebral ventricular malformations with a distorted ependy-
mal lining and abnormal cerebral vascularization. The
ventricular defects associated with PDGF-C ablation,
such as asymmetry of the lateral ventricles and hypoplas-
tic development of the septum separating the lateral ven-
tricles, were unexpected since this has not been linked to
PDGFR signaling previously.1 It is likely that these ce-
rebral ventricular abnormalities are masked by the more
severe phenotype reported for PDGF-C ablation in
129/Sv background mice and by the embryonic lethality
associated with PDGFR deficiency.5,6 These findings
are of interest because the molecular mechanisms un-
derlying brain ventricle formation remain poorly under-
stood.8 Taken together, the data presented herein will aid
in our understanding of the role of PDGF-C during CNS
development, and the description of viable PDGF-C–de-
ficient mice presents an excellent genetic tool for the
study of modifier genes of PDGF signaling in mice and for
the potential to study the role of PDGF-C in adult mice.
Materials and Methods
Mouse Strains
The generation of PDGF-C–deficient mice has been de-
scribed previously.6 These mice were backcrossed onto
a C57BL/6J genetic background. For localization of
PDGFR, we used reporter mice heterozygous for green
fluorescent protein (GFP) expression in the nucleus of
PDGFR-positive cells (Pdgfr:GFP).9 All mice used were
age- and sex-matched littermate controls from heterozy-
gous breedings. The animal experiments were approved
by the local committees for animal experiments at the
University of Michigan, Ann Arbor, Michigan, and the
Karolinska Institutet, Stockholm, Sweden.
Tissue Preparation, Histologic Analysis, and
Immunostaining
Tissue preparation for sectioning and immunostaining
was conducted using standard protocols. All images
were captured using a Nikon Eclipse TE2000 inverted
microscope (Nikon Instruments Inc., Melville, NY) or,
where stated, a Zeiss LSM 510 confocal microscope
(Carl Zeiss MicroImaging GmbH, Jena, Germany) andare representative of the respective stainings. Mice were
anesthetized with chloral hydrate (450 mg/kg i.p.). After
transcardial perfusion fixation with 4% paraformaldehyde
in PBS, the brains were removed. For paraffin embed-
ding, the brains were postfixed in 4% paraformaldehyde
at 4°C overnight, and then were processed for paraffin
embedding and sectioning using standard protocols. For
frozen and sliding microtome sections, brains were post-
fixed in 4% paraformaldehyde for 1 hour at room temper-
ature and then were kept in 30% sucrose at 4°C over-
night.
Paraffin-embedded sections (6 m) were rehydrated,
followed by quenching of endogenous peroxidase activ-
ity using 3% H2O2 for 30 minutes at room temperature
and blocking of nonspecific binding in TNB blocking
buffer for 30 minutes at room temperature [TSA biotin
system (NEL700A001KT); Perkin Elmer, Waltham, MA].
The primary antibodies used were affinity-purified rabbit
antibodies directed against human PDGF-C (10 g/mL;
in-house #615, prepared as reported by Li et al2). Biotin
conjugate secondary antibodies (dilution 1:200) (BA-
1000; Vector Laboratories, Burlingame, CA) were applied
and signal amplified using the Vectastain ABC system
(PK-4001; Vector Laboratories) according to the manu-
facturer’s instructions. The signal was developed using
SIGMAFAST 3,3=-diaminobenzidine (D4418; Sigma-Aldrich,
St. Louis, MO). As negative controls, the sections were
incubated with secondary Ig or preimmune rabbit IgG
only, and in both cases, only background staining was
observed (data not shown).
For immunofluorescence, frozen sections (14 m)
were air-dried, whereas sliding microtome sections (30
m) were stained free floating in 24-well plates before
being mounted on Superfrost Plus slides (Thermo Fisher
Scientific Inc., Waltham, MA). Sections were fixed in 4%
paraformaldehyde for 10 minutes at room temperature
and were permeabilized in 0.5% Triton X-100 (Roche
Diagnostics GmbH, Mannheim, Germany) in PBS for 20
to 60 minutes at room temperature (depending on section
thickness). The primary antibodies used were podoca-
lyxin (1:100) (AF1556; R&D Systems, Minneapolis, MN),
-smooth muscle actin–Cy3 (1:300) (C6198; Sigma-Al-
drich), glial fibrillary acidic protein (GFAP; 1:1000)
(Z0334; Dako Denmark A/S, Glostrup, Denmark), S100B
(rabbit polyclonal, 1:100) (Z0311, antigen retrieval was
performed by boiling 20 minutes in retrieval solution,
S1700, Dako), NeuN (1:500) (MAB377; Millipore, Bil-
lerica, MA), Alexa Fluor 555 phalloidin (1:50) (A34055;
Invitrogen, Carlsbad, CA), glucose transporter 1 (GLUT1;
1:100) (07–1401; Millipore), CDP (CUX1; 1:10) (sc-6327;
Santa Cruz Biotechnology, Santa Cruz, CA), Ctip2 (1:
500) (ab18465; Abcam Plc, Cambridge, UK), NG2 (1:
200) (AB5320; Millipore), and Olig2 (1:100) (MABN50;
Millipore). Appropriate Alexa Fluor–conjugated secondary
antibodies (Invitrogen) were used, and the sections were
mounted using media containing DAPI (Vector Laborato-
ries). In all the immunofluorescence stainings, blocking of
nonspecific binding was performed using TNB blocking
buffer [TSA biotin system (NEL700A001KT); Perkin El-
mer]. H&E staining was performed according to standard
protocols.
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Analysis of PDGF-C Reporter Expression
Sliding microtome sections (free floating) or 1-mm brain
slices were permeabilized with 2 mmol/L MgCl2, 0.01%
sodium deoxycholate, and 0.02% Nonidet P-40 in PBS for
30 minutes at room temperature. LacZ reporter gene ex-
pression was visualized by staining with 5 mmol/L potas-
sium ferricyanide, 5 mmol/L potassium ferrocyanide, and
1 mg/mL of 5-bromo-4-chloro-3-indolyl--D-galactoside
in permeabilization solution at 37°C overnight in the dark.
Magnetic Resonance Imaging
All magnetic resonance imaging (MRI) was conducted at
the Center for Molecular Imaging, Department of Radiology,
University of Michigan. During the imaging procedure, the
mice were anesthetized with isoflurane, and the body tem-
perature was maintained using forced heated air. MRI was
performed using a 7.0T Varian MRI scanner (183-mm hor-
izontal bore; Varian Medical Systems Inc., Palo Alto, CA). A
double-tuned volume radiofrequency coil was used to scan
the head region of the mice. Coronal T2-weighted images
were acquired using a fast spin-echo sequence with the
following parameters: repetition time/effective echo time,
4000/60 ms; echo spacing, 15 ms; number of echoes, 8;
field of view, 20  20 mm; matrix, 256  128; slice thick-
ness, 0.5 mm; number of slices, 25; and number of scans,
1 (total scan time, 2 minutes). The Matlab development
environment (The MathWorks Inc., Natick, MA) was used to
assess differences in ventricular volume, and the analysis
was conducted blinded.
Statistical Analysis
All quantifications were made using ImageJ if not stated
otherwise. All measurements are depicted as mean SEM
from the number of observations stated in the figure leg-
ends. The individual observations are based on analysis of
two to five fields of vision from comparable anatomical po-
sitions. For analysis of the Kaplan-Meier survival plot, a
log-rank test was used; for all other analyses, a Wilcoxon
two-sample test was used, with statistical significance de-
fined as *P  0.05, **P  0.01, and ***P  0.001.
Results
Expression of PDGF-C in the Murine Brain
Because our previous findings indicated that PDGF-C/
PDGFR signaling was involved in the regulation of
blood-brain barrier function, we were interested in obtain-
ing a better understanding of the role of this signaling
cascade in the adult murine CNS. For our initial analysis,
we first mapped the expression pattern of PDGF-C in
adult brain by immunohistochemical staining. These
studies revealed high expression of PDGF-C protein in
wild-type adult murine brain, especially in limbic struc-
tures, such as the septal nucleus (septum) separating the
lateral ventricles, cerebral cortex, hippocampus, andamygdala (Figure 1A). This expression pattern was
largely confirmed in Pdgfc/ and Pdgfc/ C57BL/6
mice by expression of the lacZ reporter targeted to the
Pdgfc locus (Figure 1B).6
Postnatal Survival of PDGF-C–Deficient Mice on
a C57BL/6 Background
It has previously been reported that PDGF-C–deficient
mice on a 129/Sv background (Pdgfc:129/Sv) all die be-
fore weaning, possibly due to respiratory and feeding
problems caused by a complete cleft of the secondary
palate.6 When backcrossed onto a C57BL/6 background,
Pdgfc ablation (herein referred to as Pdgfc/ mice) re-
sulted in a much less severe phenotype, thus opening the
possibility of studies in adult PDGF-C–deficient mice. We
found that a large proportion, 20% (expected, 25%), of
the Pdgfc/ mice survived the perinatal period (Figure
2A). However, we noted a sex-specific survival where
significantly fewer Pdgfc/ males, 8.5% (expected,
12.5%), were viable at weaning. Some spontaneous
deaths were also recorded in the Pdgfc/ mice after
weaning (three females and two males; Figure 2B). Post-
natal surviving Pdgfc/ mice, both females and males,
looked normal overall except for being 20% smaller
than wild-type controls (Figure 2C). This runted pheno-
type was recorded at all ages checked (4 to 15 months).
Pdgfc/ mice also presented with spina bifida occulta,
an incomplete closure of one or a few vertebrae in the
spinal column (data not shown), a skeletal defect previ-
Figure 1. Expression of PDGF-C in the murine brain. A: Immunostainings
for PDGF-CC protein in the adult murine brain (n  4). High immunoreac-
tivity was seen in limbic areas such as the cerebral cortex (right panel, top
box), hippocampus (right panel, middle box), and amygdala (right
panel, lower box) of wild-type mice (boxed areas enlarged). High immu-
noreactivity was also detected in the septum (arrowhead, middle panel),
a limbic region that separates the lateral ventricles (LVs). B: LacZ reporter
gene expression analysis in 1-mm-thick sections of adult Pdgfc/ and
Pdgfc/ brains (n  5). 5-Bromo-4-chloro-3-indolyl--D-galactoside staining
(blue) represents Pdgfc gene activity. High Pdgfc gene activity was recorded in
limbic areas such as the cerebral cortex (arrows) and in the septum (arrow-
heads). Wild-type brains were used as negative controls (n  4).ously observed in Pdgfc:129/Sv–deficient mice.6 In addi-
te contr
represen
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fewer and smaller litters (data not shown).
Abnormal Vascular Bed in PDGF-C–Deficient
Murine Brain
Pdgfc: 129/Sv-deficient mice were reported to experi-
ence subcutaneous edema formation and hemorrhage of
extracranial vessels, which are signs of vascular defects
and abnormal vascular permeability.6 Immunofluores-
cent stainings using podocalyxin antibodies, a marker for
vascular endothelial cells, and -smooth muscle actin
antibodies, a marker for vascular smooth muscle cells
(vSMCs), also revealed abnormal vascularization in the
brains of adult Pdgfc/ mice compared with wild-type
controls (Figure 3, A–D). In wild-type brains, the vascular
bed appeared uniform, with equally sized vessels evenly
distributed throughout the entire area analyzed, whereas
in Pdgfc/ brains, the vascular bed was more variable,
with an apparent increase in larger-diameter vessels rel-
ative to wild-type mice. This was confirmed by quantifi-
cation of the podocalyxin stainings, showing a significant
overall increase in vessel density (Figure 3E) and diam-
eter (Figure 3F) in Pdgfc/ mice compared with wild-
type littermate controls. Staining and quantification with
CD31 antibodies (platelet-endothelial cell adhesion mol-
ecule 1) (data not shown) achieved similar results. This is
consistent with previous studies of murine tumor models
illustrating that overexpression of PDGF-C causes a de-
crease in vessel diameter,10,11 whereas down-regulation
of PDGF-C expression causes a shift to larger-diameter
vessels compared with controls.11 Quantification of the
-smooth muscle actin–positive staining in Pdgfc/ mice
demonstrated significantly more vSMC coverage com-
pared with wild-type controls (Figure 3G). This finding was
unexpected as increased vSMC coverage is suggestive of
a more mature vascular network. However, the vSMCs did
not seem to show normal organization around the vessels in
Pdgfc/ mice; instead of forming a tight and uniform su-
perficial layer around the endothelium as seen in wild-type
mice, the vSMCs in Pdgfc/ mice were partially dissoci-
Figure 2. Postnatal survival and weight of Pdgfc/ mice. A: Distribution o
fewer Pdgfc/ mice were alive at weaning owing to a loss of Pdgfc/
recorded for Pdgfc/mice after weaning than for wild-type littermate contro
of age. Pdgfc/ mice were significantly smaller than their wild-type litterma
on the respective bars. *P  0.05, **P  0.01, and ***P  0.001. Error barsated from the abluminal endothelial cell surface (Figure 3, Cand D). In contrast, the microvascular capillaries in the adult
murine brain of Pdgfc/ mice seemed to have normal
coverage of pericytes as visualized by immunostainings
with PDGFR and CD13 antibodies (data not shown).
Asymmetry of the Cerebral Lateral Ventricles in
PDGF-C–Deficient Mice
During the characterization of Pdgfc/ mice, we noted
that these mice presented with asymmetrical lateral ven-
tricles. Histologic analysis of Pdgfc/ brains by H&E
staining revealed that the asymmetrical lateral ventricles
seemed to coincide with displacement of the septum
toward the side of the smaller ventricle (Figure 4A). The
septum, equivalent to the septum pellucidum in humans,
is the anatomical structure that separates the lateral ven-
tricles, and its displacement in Pdgfc/ mice made the
smaller ventricle appear compressed. To ensure that the
asymmetry was not an artifact of tissue preparation, in
vivo MRI in live mice was used (Figure 4B). Quantification
of the extent of ventricular asymmetry was determined
from the H&E stainings (Figure 4C) and the MRIs (Figure
4D). For the H&E quantifications, the average size of the
respective lateral ventricle was determined using three
identical anatomical positions for each mouse and is
expressed as the ratio of the smallest to the largest ven-
tricular area (Figure 4C). This analysis suggested (P 
0.1) that the smaller of the lateral ventricles in Pdgfc/
mice was approximately half the size (mean  SEM,
53%  6%) of the larger ventricle. In wild-type controls,
the ventricles were evenly sized (the smaller being a
mean  SEM 96%  1% of the larger). Comparing the
total volume of the smallest to the largest ventricle from
the MRIs (Figure 4D) revealed significant asymmetry of
the lateral ventricles in Pdgfc/ mice (mean  SEM,
58%  5%) compared with in wild-type controls (mean 
SEM, 95% 2%), thus confirming the results of histologic
staining. In Pdgfc/ mice, asymmetry was intermediate
(mean SEM, 81% 6%) compared with that in Pdgfc/
mice and wild-typemice, indicating a gene dosage effect of
PDGF-C in the control of ventricular symmetry. Three exam-
ypes at weaning from heterozygous breedings (n  78 litters). Significantly
: Kaplan-Meier survival plot. Significantly more spontaneous deaths were
ank test). C:Weight of Pdgfc/ and wild-type littermate controls at 7 months
ols at all recorded ages (4 to 15 months). Numbers of animals are displayed
t SEM.f genot
males. B
ls (log-rples of Pdgfc/ adult mice with a hypoplastic septum were
1140 Fredriksson et al
AJP March 2012, Vol. 180, No. 3also observed by MRI (one female and two males). Figure
4E shows a montage from MRIs of an adult male illustrating
this defect. No similar defect was noted in any wild-type
animals, and Pdgfc/ mice with a hypoplastic septum
were excluded from this analysis of ventricular symmetry.
Abnormal Ventricular Lining in
PDGF-C–Deficient Mice
Based on the present findings of lateral ventricle abnor-
Figure 3. Abnormal vascularization in the brains of Pdgfc/ mice. A–D:
Immunofluorescent co-stainings of vessels using the endothelial cell marker
podocalyxin (Podo; green) and the vSMCmarker -smooth muscle actin (ASMA;
red) revealed that the vascular bed was disorganized and displayed more ASMA-
positive, large-diameter vessels in adult Pdgfc/ mouse brains compared with
wild-type littermate controls (A and B). The pictures in C and D are two-
dimensional renderings of the three-dimensional pictures made from confocal
Z-stacks and illustrate that vSMC coverage appears thicker, with defect invest-
ment around the endothelial cells in Pdgfc/ mice (arrowheads), which was
not seen in wild-type controls (arrows). Quantification of vessel density (E),
vessel diameter (F), and number of ASMA-positive vessels (G) shows signifi-
cantly more and larger vessels present in Pdgfc/ mice compared with in
wild-type controls (n 9). F:Gray bar,10 m; white bar, 5–10 m; black bar,
5 m. *P 0.05, ***P 0.001. Error bars represent SEM. The pictures in B are
single-plane confocal images. LV, lateral ventricle.malities in Pdgfc/ mice and a previous study showinghigh expression of PDGF-C in cells surrounding the ven-
tricles in the developing murine brain,12 we next exam-
ined the integrity of the ependymal cell layer lining the
lateral ventricles in adult PDGF-C mutant mice.
In Pdgfc/ mice, we noted that the ependymal lining,
herein visualized by the ependymal marker S100,13 was
poorly formed. It appeared convoluted and pleomorphic
(Figure 5A) and seemed to easily separate from the un-
derlying subependymal cell layer (data not shown). Also,
areas of ependymal denudation were seen in Pdgfc/
brains (Figure 5A). These stainings further revealed that
the normal cuboidal shape of ependymal cells was often
lost in Pdgfc/ animals (Figure 5A). Immunostaining with
phalloidin antibodies against F-actin revealed that the
strong apical border staining seen in wild-type
ependyma was abnormal and only weakly present in
Pdgfc/ mutant ependyma (Figure 5B). Furthermore,
staining with antibodies against GLUT1 a marker for ma-
ture ependyma,14 showed a decrease in GLUT1 expres-
sion in Pdgfc/ ependyma (Figure 5C) compared with
wild-type controls. Taken together, these results demon-
strate that ablation of PDGF-C signaling affects ependy-
mal differentiation and integrity.
In addition to ependymal abnormalities, staining of
subventricular cells with GFAP antibodies revealed that
the subventricular lining of the lateral ventricles was
highly irregular in Pdgfc/ mice (Figure 5D). Discontin-
uous GFAP staining was observed in most (90%) of the
Figure 4. Lateral ventricular defects in the brains of Pdgfc/ mice. Ex vivo
H&E stainings (A) and in vivo MRIs (B) of Pdgfc/ and wild-type adult
brains. The septum separating the lateral ventricles (LVs; arrows) seemed
displaced in Pdgfc/ mice (arrowheads). Quantification of the ratio be-
tween the smallest to the largest ventricular size from the H&E stainings (C)
and the MRIs (D) confirmed that Pdgfc/ mice displayed significant asym-
metry in LV size compared with wild-type littermate controls. Numbers of
analyzed animals are displayed on the respective bars. *P  0.05, **P  0.01,
and ***P  0.001. Error bars represent SEM. E: Montage from MRIs of a
Pdgfc/ male mouse illustrating hypoplasia of the septum (arrow). The
quantifications were made in C using ImageJ to trace the area of the right and
left ventricles from three anatomically similar fields of vision and in D using
Matlab to trace the entire volume for each LV.
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(20%). These GFAP-positive subventricular zone (SVZ)
astrocytes, also referred to as type B cells, are believed
to be the neural stem cells of the adult mammalian
brain.15 Note that these type B cells have been reported
to express PDGFR in the adult SVZ.16
Cortical Lamination in PDGF-C–Deficient Murine
Brain
A recent study has linked PDGF-C signaling to neuronal
survival in vitro,17 prompting us to study the effect of
PDGF-C ablation on the neuronal population in Pdgfc/
mice. Staining for NeuN, a marker for mature neurons,
Figure 5. Abnormal ependymal lining of the lateral ventricles (LVs) in
Pdgfc/ mice. A–C: Immunofluorescent stainings of adult control and
Pdgfc/ ependymal cell linings of the lateral wall of the LVs using S100B
(A), phalloidin (B), and GLUT1 (C) antibodies. A: Note the tortuous ependy-
mal lining (arrows) and the occasional gaps in the ependyma (arrow-
heads) of Pdgfc/ mutant mice. Each picture is a representative from
different individuals. B and C also note the low levels of apical phalloidin
staining (arrows; B) and GLUT1 staining (arrows; C) in Pdgfc/ mice
compared with littermate controls. D: Immunofluorescent stainings of sub-
ependymal astrocytes with antibodies against GFAP show highly irregular
staining in Pdgfc/ mice around the LV (arrows) compared with wild-type
littermate controls. Low-magnification images in A and D are single-plane
confocal micrographs, whereas the other pictures are two-dimensional ren-
derings of the three-dimensional pictures made from confocal Z-stacks (n 
8). Cell nuclei were visualized by using DAPI (blue).indicated that the distribution of NeuN-positive cells inPdgfc/ mice was similar to that in wild-type mice (Fig-
ure 6A). These NeuN stainings revealed areas around the
lateral ventricles in Pdgfc/ mice where NeuN-positive
neurons disrupted the ependymal cell lining (Figure 6, A
and B). This disruption was not seen in wild-type controls.
The boxed areas in Figure 6A are magnified in Figure 6B.
Such misplaced neurons are suggestive of a neuronal
migration defect since it is possible that these ectopic
neurons have failed to migrate to their proper position in
the cerebral cortex. To determine whether PDGF-C defi-
ciency results in defects in neuronal migration, we ana-
lyzed the cortical lamination in adult Pdgfc/ mice using
various layer-specific neuronal markers (Figure 6C).
Staining for CUX-1 (layers II to IV) and Ctip2 (layer V)
showed an overall normal-looking cortex in Pdgfc/
mice, although layer V appeared modestly, but not sig-
nificantly, increased in Pdgfc/ mice (Figure 6D).
Target Cells of PDGF-C Signaling in the Adult
Murine Brain
Expression of PDGFR in the CNS, the receptor for
PDGF-C,2 has been extensively studied, and it is well
established that PDGFR signaling is essential for glial
cell development.18,19 However, some studies have sug-
gested that PDGFR is also expressed by mature neu-
rons in the adult mammalian CNS, and it has been pro-
posed that PDGF-C/PDGFR signaling may be critical for
neuronal survival in vitro.17,20 Owing to these discrepan-
cies regarding the expression and role of PDGFR in the
CNS, we next examined where PDGFR is expressed in
the adult murine brain to see potential target cells of
PDGF-C signaling. For this analysis, we used Pdgfr:GFP
reporter mice.9 Staining of brain sections from adult
Pdgfr:GFP mice with the general neuronal maker NeuN,
expressed in the nucleus of mature neurons, revealed no
evidence of expression of PDGFR in mature neurons in
vivo (Figure 7A). In fact, we did not encounter any nuclei
with overlapping expression of PDGFR reporter (green)
and NeuN (red); however, the red and green nuclei often
appeared in close proximity to each other, supporting the
idea of close communication between neurons and
PDGFR-expressing cells. These results, indicating no
expression of PDGFR in mature neurons in the adult
CNS, are consistent with the normal appearance of cor-
tical neuronal layering in the brains of Pdgfc/ mice
(Figure 6). Co-stainings of brain sections from adult
PDGFR reporter mice with various glial markers re-
vealed that the PDGFR reporter gene was expressed in
glial cells such as arteriole-associated astrocytes (Figure
7B), oligodendrocytes (Figure 7C), and NG2-positive oli-
godendrocyte progenitors (Figure 7D). Together, these
data suggest that in vivo PDGF-C is not critically required
for neuronal survival through PDGFR signaling on neu-
rons. Instead, the present data are consistent with
studies suggesting that PDGFR may be important for
glial cell development and survival (reviewed by An-
drae et al1).
Ablation of PDGF-A, the other known ligand for
PDGFR, has been reported to decrease the number of
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brain.19 However, PDGF-A ablation has only intermediate
effects on the number of oligodendrocytes in the cerebral
cortex. Since PDGF-C is highly expressed in the adult
cerebral cortex (Figure 1, A and B) and PDGFR is ex-
pressed in oligodendrocytes and NG-2 progenitors (Fig-
ure 7, C and D), we investigated whether ablation of
PDGF-C decreased the number of oligodendrocyte pro-
genitors in this area of the brain. We found that the num-
ber of NG-2 positive glia in the cortex of adult Pdgfc/
mice was similar to that of wild-type controls (Figure 7E). It
is, however, still possible that PDGF-C functions in parallel
with PDGF-A during embryonic and perinatal oligodendro-
genesis in the cerebral cortex but that this is not apparent in
the surviving adult Pdgfc/ mice studied herein.
Discussion
This study shows that loss of PDGF-C in C57BL/6 mice is
compatible with postnatal survival, offering the opportu-
nity to study the physiologic and pathophysiologic roles
of this protein in the adult mouse. However, despite post-
natal survival, these data demonstrate the presence of
significant congenital defects in the CNS of Pdgfc/
mice, such as spina bifida occulta, cerebral vascular
abnormalities, and asymmetrical lateral ventricles with
distorted ependymal lining. The milder phenotype of
PDGF-C ablation in C57BL/6 mice will facilitate the study
of developmental roles of PDGF-C, obscured by the more
severe phenotype seen in Pdgfc:129/Sv mice.6 The ob-
servation that phenotype severity depends on genetic
background also offers an opportunity to study modifier
genes of PDGF signaling in mice.
The unexpected finding that PDGF-C ablation in
C57BL/6 mice is associated with cerebral ventricular de-
fects was especially intriguing, first because this has not
been linked to PDGFR signaling previously1 and sec-
ond because the molecular mechanisms underlyingbrain ventricle formation still remain poorly understood.8
The smaller ventricle in Pdgfc/ mice seemed to arise
from displacement of the septum, ie, the structure that
separates the lateral ventricles. In some Pdgfc/ mice,
we even noted incomplete development of the septum,
which is reminiscent of cavum septum pellucidum seen in
humans. A cavum of the septum is often present at birth
but is normally eliminated by age 3 to 6 months as the
septal leaves fuse postnatally in a posterior-to-anterior
manner.21 Preservation of a cavum septum pellucidum in
adults is a marker for fetal neural maldevelopment, al-
though the cause is largely unknown.22 However, it has
been suggested that it is likely due to underdevelopment
of limbic structures, such as the hippocampus, amygda-
lae, and septal nuclei,23,24 ie, structures where we report
high expression of PDGF-C. A persistent cavum septum
pellucidum in the adult population has also been associ-
ated with craniofacial malformations, such as clefts of the
lip and/or palate.25 As mentioned previously herein,
PDGF-C ablation in 129/Sv mice results in a complete
cleft of the secondary palate,6 and mutations in the hu-
man PDGFC gene have recently been shown to strongly
associate with clefts of the lip and/or palate.26,27
The cerebral ventricles in adult mammals are normally
lined with an uninterrupted single layer of specialized
epithelial cells, the ependymal cells, that are important for
normal brain function.28 The present study shows that
PDGF-C ablation causes defects in the ependymal lining
of the lateral ventricles and in the underlying SVZ. These
defects are characterized by the loss of the normal cuboi-
dal ependymal cell shape and by ependymal denudation
and loss of GFAP-positive cells in the SVZ, indicating that
PDGF-C/PDGFR signaling regulates the formation of
normal lateral ventricle lining. These observations are of
particular interest since the SVZ is believed to be the
source of neuronal and oligodendrocyte stem cells in the
adult brain and the molecular mechanism guiding
Figure 6. Ectopic neurons in the ventricular lin-
ing but normal cortical lamination in Pdgfc/
mice. A–C: Immunofluorescent stainings for ma-
ture neurons with NeuN antibodies illustrated
overall normal distribution of NeuN-positive
cells in Pdgfc/ mice; however, misplaced
NeuN-positive neurons were noted in the
ependymal cell lining of Pdgfc/ mice (arrow-
heads; A and B) but not of wild-type controls.
Boxed areas in A are magnified in B. C: Stainings
for layer II to IV neurons with CUX-1 antibodies
and layer V neurons with Ctip2 antibodies
showed that Pdgfc/ mice displayed a cerebral
cortical lamination comparable with that of wild-
type littermate controls. The width of the respec-
tive layers was measured as the distance be-
tween the dashed lines in C and is quantified in
D (n  7). A slight, although nonsignificant,
increase in the width of layer V was noted. Cell
nuclei were visualized by using DAPI (blue).
Error bars represent SEM. LV, lateral ventricle.ependymal differentiation is not yet fully understood.15
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loss of PDGF-C disrupts the important ependymal layer
directly, or indirectly by affecting the stem cell population
in the SVZ, it is tempting to speculate that loss of PDGF-C
during development affects the pool of radial glia which
are giving rise to both ependymal as well as GFAP/
PDGFR-positive cells in the SVZ.16,29,30 Note that this
subset of radial glia is derived from the neuroepithelium,
which is known to display high expression of PDGFR as
early as embryonic day 8.5 (E8.5),31 and that the first
evidence of ependymal differentiation is seen in the floor
plate of the neural tube, a structure in which high expression
of PDGF-C has been reported.12 It will be interesting to use
the PDGF-C mutants characterized herein to further estab-
lish the molecular mechanism of how PDGF signaling
guides ependymal/SVZ development.
Ependymal malformations and loss of neuroependy-
mal integrity have been linked to hydrocephalus and
Figure 7. Expression of Pdgfr in the adult murine brain. Adult murine brain
sections from Pdgfr:GFP reporter mice were stained with NeuN (A), GFAP
(B), Olig2 (C), and NG2 (D) antibodies. Pdgfr reporter (GFP) (arrows) was
not expressed by mature NeuN-positive neurons (arrowheads; A) but was
found to be expressed by various macroglial cells, including vessel-associ-
ated astrocytes (arrowheads; B), oligodendrocytes (arrowheads; C), and
NG2-glia (arrowheads; D). Co-expression is visualized as yellow in the
overlay pictures (double-arrows; B–D). B: Podocalyxin (blue) was used to
visualize vessels. E: Immunostainings for NG2-glia in Pdgfc/ and wild-type
littermate controls revealed a normal distribution in adult Pdgfc/ mutant
brains (n  5). The pictures are two-dimensional renderings of the three-
dimensional pictures made from confocal Z-stacks.neural tube defects and to neuronal migrational de-fects.32,33 In the lateral ventricular wall of Pdgfc/ mice,
we found misplaced neurons disrupting the ependymal
lining, a feature seen in patients diagnosed as having the
neuronal migrational disorder periventricular nodular het-
erotopia34 and in victims of sudden infant death syn-
drome.35 In addition, we also found one Pdgfc/ male
mouse (sacrificed at 7 months of age) with extreme hydro-
cephalus, manifested as an abnormal accumulation of ce-
rebrospinal fluid and enlargement of the lateral ventricles.
Whether these defects are due to ependymal abnormalities
associated with PDGF-C ablation remains to be deter-
mined.
Based on our earlier findings, we suggested that
PDGF-C and its receptor PDGFR are “drugable” targets
in the management of ischemic stroke in mice,4 and a
clinical trial has been initiated to evaluate the safety and
feasibility of inhibiting the PDGF-C/PDGFR signaling
pathway in patients with stroke (I-STROKE Trial of the
European Stroke Network). The rationale is that targeting
this signaling pathway will extend the relatively short
treatment window of thrombolytic therapy by protecting
the integrity of the blood-brain barrier. However, for this to
succeed, it is important to know that PDGF-C is also
expressed in the neurovascular unit in human brains. In
studies performed in parallel with those reported herein,
we find that the expression pattern of PDGF-C in the
human brain seems to be conserved, with high expres-
sion in limbic regions, such as in the cortical gray matter
and around cerebrovascular arterioles (data not shown).
This similar pattern of distribution to that seen in mice,
including localization around the arterioles, supports a
role for PDGF-C in the neurovascular unit in humans.
A recent study has suggested that PDGF-C is a potent
neuroprotective factor and cautioned against inhibition of
the PDGF-C/PDGFR signaling pathway in clinical neu-
ropathology.17 However, the present data do not support
a role for PDGF-C as a neuronal survival factor in vivo
because in this study, Pdgfc/mice displayed apparent
normal distribution of neurons in the brain despite com-
plete ablation of PDGF-C and, importantly, because we
found no evidence of PDGFR expression on mature
neurons in vivo. The present results are also consistent
with those of studies that have shown that PDGFR is
critical for oligodendrogenesis but not for neurogen-
esis.1,16 In contrast to a neuronal phenotype, the present
data demonstrate the presence of significant nonneuro-
nal congenital defects in the CNS of Pdgfc/ mice, in-
cluding cerebral vascular and ventricular abnormalities.
These developmental defects were not noted in the study
by Tang and colleagues17 and substantially complicate
the interpretation of their experimental data obtained with
Pdgfc/ mice. We suggest that these congenital abnor-
malities need to be considered when using Pdgfc/
mice as a genetic tool in the investigation of pathophys-
iologic roles of PDGF-C and PDGFR in the adult CNS.
Finally, an independent study has confirmed our previous
observation that blocking PDGFR signaling in vivo pro-
tects the integrity of the blood-brain barrier.36
In conclusion, these data demonstrate that PDGF-C
plays an important role in the formation of normal cerebral
vascularization and normal cerebral ventricles and in
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ized herein present an excellent genetic tool for further
unraveling aspects and underlying molecular mecha-
nisms of cerebral ventricle and ependymal development
and differentiation. Also, it will be interesting to use these
postnatally surviving Pdgfc/ mice to study the link be-
tween PDGF signaling, ependymal/ventricular anomalies,
and neuropathologic conditions, such as cavum septum
pellucidum and hydrocephalus, and to gain further in-
sight into the stem cell compartment in the SVZ.
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